Myb permits multilineage airway epithelial cell differentiation

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Molecular Biology

Background:

• Airway epithelium defends against insults but can undergo dysregulated differentiation, leading to lung disease.
• Current models propose a one-step airway epithelial differentiation from basal progenitors, with limited understanding of cues and intermediate steps.

Purpose of the Study:

• To identify key regulators of early airway epithelial multilineage differentiation.
• To investigate the role of transcription factor Myb in airway epithelial cell development and its potential link to lung disease.

Main Methods:

• Investigated transcription factor Myb's role using RNA interference (RNAi) in primary airway epithelial cells.
• Utilized Myb gene deletion in mice to study its in vivo function.
• Analyzed whole-genome expression in Myb-deficient cells.
• Examined human airway samples, including those from patients with chronic obstructive pulmonary disease (COPD).

Main Results:

• Identified Myb as a key regulator enabling early multilineage differentiation of airway epithelial cells.
• Discovered Myb-positive cells are p63-negative, distinct from basal progenitors, and represent an undifferentiated intermediate stage.
• Myb deficiency led to impaired maturation of ciliated (Foxj1+) and secretory (Scbg1a1+, Muc5ac+) cells.
• Myb-dependent gene expression programs for ciliated and secretory cell differentiation were identified.
• Myb-positive cells were increased in human airways with ciliated and mucous cell hyperplasia in COPD samples.

Conclusions:

• A p63-negative, Myb-positive airway epithelial cell population represents a distinct intermediate differentiation stage essential for normal lung homeostasis.
• This intermediate stage is critical for proper ciliated and secretory cell development.
• The heightened presence of Myb-positive cells in COPD suggests their potential involvement in airway disease pathogenesis.